Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Nabi Biopharmaceuticals

ClinicalTrials.gov Identifier:

NCT00063089

First received: June 19, 2003

Last updated: May 10, 2012

Last verified: May 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2004
Primary Completion Date:	September 2004 (Final data collection date for primary outcome measure)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):